TOPICS

Tag: Cutaneous T-Cell Lymphoma

Talimogene Laherparepvec in Non-Melanoma Cancers

J Clin Aesthet Dermatol. 2021;14(11):18–25. by Antoine Salloum, MD; Jenna Koblinski, MD; Nagham Bazzi, MD; and Nathalie C. Zeitouni, MDCM, FRCPC Dr. Salloum is with the Department of Dermatology at Saint George Hospital University Medical Center in Beirut, Lebanon, and Dermatologic Surgicenter in Philadelphia, Pennsylvania. Drs. Koblinski and Zeitouni are with the University of Arizona

CONTINUE READING »

Strategies for Treating Cutaneous T-Cell Lymphoma Part 1: Remission

Jo-Ann Latkowski, MD, New York University School of Medicine, New York, New York; Peter Heald, MD, Yale University School of Medicine, New Haven, Connecticut Abstract In this article, the management of cutaneous T-cell lymphoma will be presented in terms of the strategies that guide treatment. With the strategies and goals in mind, treatment options to

CONTINUE READING »